NEU1 and cardiomyopathy: Third, although the cardio-protective effect of NEU1 inhibitor against DOX-induced cardiomyopathy was remarkable in animal models, a large number of clinical trials are needed to confirm the efficacy of existing anti-viral drugs like OSE in DOX-induced cardiomyopathy treatment.